| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| AKTS AKTIS ONCOLOGY, INC. | SALE Chief Product Officer | 880 | $8.15 | $7.2K | 132,767 | Aug 23, 2021 | Aug 24, 2021 ↗ |
| AKTS AKTIS ONCOLOGY, INC. | SALE Chief Product Officer | 1,375 | $8.96 | $12.3K | 133,647 | Jul 19, 2021 | Jul 20, 2021 ↗ |
| AKTS AKTIS ONCOLOGY, INC. | SALE Chief Product Officer | 1,375 | $13.82 | $19.0K | 135,022 | Mar 15, 2021 | Mar 17, 2021 ↗ |
| AKTS AKTIS ONCOLOGY, INC. | SALE Chief Product Officer | 99,800 | $14.13 | $1.41M | 136,397 | Mar 11, 2021 | Mar 12, 2021 ↗ |
| AKTS AKTIS ONCOLOGY, INC. | SALE Chief Product Officer | 880 | $11.07 | $9.7K | 236,197 | Dec 21, 2020 | Dec 23, 2020 ↗ |
| AKTS AKTIS ONCOLOGY, INC. | SALE Chief Product Officer | 1,100 | $7.70 | $8.5K | 237,077 | Nov 24, 2020 | Nov 25, 2020 ↗ |
| AKTS AKTIS ONCOLOGY, INC. | SALE Chief Product Officer | 2,200 | $8.37 | $18.4K | 238,177 | Sep 28, 2020 | Sep 30, 2020 ↗ |
| AKTS AKTIS ONCOLOGY, INC. | SALE Chief Product Officer | 8,750 | $7.64 | $66.8K | 240,377 | Sep 14, 2020 | Sep 16, 2020 ↗ |
| AKTS AKTIS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Aug 28, 2020 | Sep 1, 2020 ↗ |
| AKTS AKTIS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 249,127 | Aug 28, 2020 | Sep 1, 2020 ↗ |
| AKTS AKTIS ONCOLOGY, INC. | SALE Chief Product Officer | 1,400 | $8.58 | $12.0K | 224,127 | Aug 21, 2020 | Aug 25, 2020 ↗ |
| AKTS AKTIS ONCOLOGY, INC. | SALE Chief Product Officer | 2,200 | $7.90 | $17.4K | 225,527 | Jul 17, 2020 | Jul 21, 2020 ↗ |
| AKTS AKTIS ONCOLOGY, INC. | SALE Chief Product Officer | 2,200 | $4.22 | $9.3K | 227,727 | Mar 13, 2020 | Mar 17, 2020 ↗ |